BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sacheli R, Delacroix L, Vandenackerveken P, Nguyen L, Malgrange B. Gene transfer in inner ear cells: a challenging race. Gene Ther 2013;20:237-47. [PMID: 22739386 DOI: 10.1038/gt.2012.51] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Kim SM, Wang W, Cai C, Feng Y, Kong W, Lin X. Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success. Front Mol Neurosci 2018;11:221. [PMID: 29997477 DOI: 10.3389/fnmol.2018.00221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
2 Wu X, Zhang W, Li Y, Lin X. Structure and Function of Cochlear Gap Junctions and Implications for the Translation of Cochlear Gene Therapies. Front Cell Neurosci 2019;13:529. [PMID: 31827424 DOI: 10.3389/fncel.2019.00529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gao X, Tao Y, Lamas V, Huang M, Yeh WH, Pan B, Hu YJ, Hu JH, Thompson DB, Shu Y, Li Y, Wang H, Yang S, Xu Q, Polley DB, Liberman MC, Kong WJ, Holt JR, Chen ZY, Liu DR. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature. 2018;553:217-221. [PMID: 29258297 DOI: 10.1038/nature25164] [Cited by in Crossref: 234] [Cited by in F6Publishing: 199] [Article Influence: 58.5] [Reference Citation Analysis]
4 Ahmed H, Shubina-Oleinik O, Holt JR. Emerging Gene Therapies for Genetic Hearing Loss. J Assoc Res Otolaryngol 2017;18:649-70. [PMID: 28815315 DOI: 10.1007/s10162-017-0634-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 11.5] [Reference Citation Analysis]
5 Müller U, Barr-Gillespie PG. New treatment options for hearing loss. Nat Rev Drug Discov 2015;14:346-65. [PMID: 25792261 DOI: 10.1038/nrd4533] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 14.7] [Reference Citation Analysis]
6 Jeschke M, Moser T. Considering optogenetic stimulation for cochlear implants. Hear Res 2015;322:224-34. [PMID: 25601298 DOI: 10.1016/j.heares.2015.01.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
7 Lan Y, Tao Y, Wang Y, Ke J, Yang Q, Liu X, Su B, Wu Y, Lin CP, Zhong G. Recent development of AAV-based gene therapies for inner ear disorders. Gene Ther 2020;27:329-37. [PMID: 32424232 DOI: 10.1038/s41434-020-0155-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jimenez JE, Nourbakhsh A, Colbert B, Mittal R, Yan D, Green CL, Nisenbaum E, Liu G, Bencie N, Rudman J, Blanton SH, Zhong Liu X. Diagnostic and therapeutic applications of genomic medicine in progressive, late-onset, nonsyndromic sensorineural hearing loss. Gene 2020;747:144677. [PMID: 32304785 DOI: 10.1016/j.gene.2020.144677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Scheper V, Hoffmann A, Gepp MM, Schulz A, Hamm A, Pannier C, Hubka P, Lenarz T, Schwieger J. Stem Cell Based Drug Delivery for Protection of Auditory Neurons in a Guinea Pig Model of Cochlear Implantation. Front Cell Neurosci 2019;13:177. [PMID: 31139049 DOI: 10.3389/fncel.2019.00177] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
10 Yamoah EN, Li M, Shah A, Elliott KL, Cheah K, Xu PX, Phillips S, Young SM Jr, Eberl DF, Fritzsch B. Using Sox2 to alleviate the hallmarks of age-related hearing loss. Ageing Res Rev 2020;59:101042. [PMID: 32173536 DOI: 10.1016/j.arr.2020.101042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
11 Liu H, Chen S, Zhou Y, Che X, Bao Z, Li S, Xu J. The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution. Journal of Drug Targeting 2013;21:846-54. [DOI: 10.3109/1061186x.2013.829075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.9] [Reference Citation Analysis]
12 Jiang H, Wang L, Beier KT, Cepko CL, Fekete DM, Brigande JV. Lineage analysis of the late otocyst stage mouse inner ear by transuterine microinjection of a retroviral vector encoding alkaline phosphatase and an oligonucleotide library. PLoS One 2013;8:e69314. [PMID: 23935981 DOI: 10.1371/journal.pone.0069314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
13 Khalin I, Alyautdin R, Kocherga G, Bakar MA. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int J Nanomedicine 2015;10:3245-67. [PMID: 25995632 DOI: 10.2147/IJN.S77480] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
14 Géléoc GGS, El-Amraoui A. Disease mechanisms and gene therapy for Usher syndrome. Hear Res 2020;394:107932. [PMID: 32199721 DOI: 10.1016/j.heares.2020.107932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
15 Gu X, Chai R, Guo L, Dong B, Li W, Shu Y, Huang X, Li H. Transduction of Adeno-Associated Virus Vectors Targeting Hair Cells and Supporting Cells in the Neonatal Mouse Cochlea. Front Cell Neurosci 2019;13:8. [PMID: 30733670 DOI: 10.3389/fncel.2019.00008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
16 Delmaghani S, El-Amraoui A. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges. J Clin Med 2020;9:E2309. [PMID: 32708116 DOI: 10.3390/jcm9072309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
17 Valentini C, Szeto B, Kysar JW, Lalwani AK. Inner Ear Gene Delivery: Vectors and Routes. Hearing Balance Commun 2020;18:278-85. [PMID: 33604229 DOI: 10.1080/21695717.2020.1807261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 György B, Sage C, Indzhykulian AA, Scheffer DI, Brisson AR, Tan S, Wu X, Volak A, Mu D, Tamvakologos PI, Li Y, Fitzpatrick Z, Ericsson M, Breakefield XO, Corey DP, Maguire CA. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV. Mol Ther 2017;25:379-91. [PMID: 28082074 DOI: 10.1016/j.ymthe.2016.12.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 27.0] [Reference Citation Analysis]
19 Géléoc GS, Holt JR. Sound strategies for hearing restoration. Science 2014;344:1241062. [PMID: 24812404 DOI: 10.1126/science.1241062] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 17.9] [Reference Citation Analysis]
20 El-Shamayleh Y, Horwitz GD. Primate optogenetics: Progress and prognosis. Proc Natl Acad Sci U S A 2019:201902284. [PMID: 31871196 DOI: 10.1073/pnas.1902284116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
21 Nourbakhsh A, Colbert BM, Nisenbaum E, El-Amraoui A, Dykxhoorn DM, Koehler KR, Chen ZY, Liu XZ. Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art. J Assoc Res Otolaryngol 2021;22:95-105. [PMID: 33507440 DOI: 10.1007/s10162-020-00781-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chang Q, Wang J, Li Q, Kim Y, Zhou B, Wang Y, Li H, Lin X. Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange-Nielsen deafness syndrome. EMBO Mol Med 2015;7:1077-86. [PMID: 26084842 DOI: 10.15252/emmm.201404929] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
23 Devare J, Gubbels S, Raphael Y. Outlook and future of inner ear therapy. Hear Res 2018;368:127-35. [PMID: 29804723 DOI: 10.1016/j.heares.2018.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
24 Yu Q, Wang Y, Chang Q, Wang J, Gong S, Li H, Lin X. Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice. Gene Ther 2014;21:71-80. [PMID: 24225640 DOI: 10.1038/gt.2013.59] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 8.9] [Reference Citation Analysis]
25 Kohrman DC, Raphael Y. Gene therapy for deafness. Gene Ther 2013;20:1119-23. [PMID: 23864018 DOI: 10.1038/gt.2013.39] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
26 Blanc F, Mondain M, Bemelmans AP, Affortit C, Puel JL, Wang J. rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application. J Clin Med 2020;9:E589. [PMID: 32098144 DOI: 10.3390/jcm9020589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Kleinlogel S, Vogl C, Jeschke M, Neef J, Moser T. Emerging approaches for restoration of hearing and vision. Physiological Reviews. [DOI: 10.1152/physrev.00035.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
28 Iizuka T, Kamiya K, Gotoh S, Sugitani Y, Suzuki M, Noda T, Minowa O, Ikeda K. Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness. Hum Mol Genet 2015;24:3651-61. [PMID: 25801282 DOI: 10.1093/hmg/ddv109] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
29 Konerding WS, Janssen H, Hubka P, Tornøe J, Mistrik P, Wahlberg L, Lenarz T, Kral A, Scheper V. Encapsulated cell device approach for combined electrical stimulation and neurotrophic treatment of the deaf cochlea. Hear Res 2017;350:110-21. [PMID: 28463804 DOI: 10.1016/j.heares.2017.04.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
30 Gordon SA, Gurgel RK. Past and Future Biologics for Otologic Disorders. Otolaryngol Clin North Am 2021;54:779-87. [PMID: 34119333 DOI: 10.1016/j.otc.2021.05.003] [Reference Citation Analysis]
31 Wang J, Puel J. Toward Cochlear Therapies. Physiological Reviews 2018;98:2477-522. [DOI: 10.1152/physrev.00053.2017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
32 Taruno A, Kashio M, Sun H, Kobayashi K, Sano H, Nambu A, Marunaka Y. Adeno-Associated Virus-Mediated Gene Transfer into Taste Cells In Vivo. Chem Senses 2017;42:69-78. [PMID: 27940927 DOI: 10.1093/chemse/bjw101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Emptoz A, Michel V, Lelli A, Akil O, Boutet de Monvel J, Lahlou G, Meyer A, Dupont T, Nouaille S, Ey E, Franca de Barros F, Beraneck M, Dulon D, Hardelin JP, Lustig L, Avan P, Petit C, Safieddine S. Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G. Proc Natl Acad Sci U S A 2017;114:9695-700. [PMID: 28835534 DOI: 10.1073/pnas.1708894114] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 13.8] [Reference Citation Analysis]
34 Akil O. Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear. Hearing Research 2020;394:107912. [DOI: 10.1016/j.heares.2020.107912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
35 Wang H, Bing D, Li J, Xie L, Xiong F, Lan L, Wang D, Guan J, Wang Q. High Frequency of AIFM1 Variants and Phenotype Progression of Auditory Neuropathy in a Chinese Population. Neural Plast 2020;2020:5625768. [PMID: 32684920 DOI: 10.1155/2020/5625768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]